Antisense inhibition of human Akt-2 expression

  • US 6,043,090 A
  • Filed: 03/23/1999
  • Issued: 03/28/2000
  • Est. Priority Date: 03/23/1999
  • Status: Expired due to Term
First Claim
Patent Images

1. An antisense compound 8 to 30 nucleotides in length targeted to a 5'"'"' UTR, coding or a 3'"'"' UTR of a nucleic acid molecule encoding human Akt-2, wherein said antisense compound inhibits the expression of human Akt-2.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×